The Food and Drug Administration gave Johnson & Johnson's vaccine the green light for emergency use Saturday, a day after a panel of advisers to the agency endorsed it in a unanimous vote.
The Food and Drug Administration released an analysis of Johnson & Johnson's COVID-19 vaccine Wednesday morning that appears to support its authorization for emergency use.
Tattoo artists are unhappy about a new ban on blue and green pigments in Europe, while scientists say the basic science of tattoo ink is still fairly mysterious.
The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.
The case was the first abortion-related decision faced by the new conservative majority of the U.S. Supreme Court after Justice Amy Coney Barrett was sworn in last year.
Agency officials said reducing the number of doses creates a potential for harm in patients because "they may assume that they are fully protected when they are not" and may "take unnecessary risks."
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.
The Food and Drug Administration says is advising health workers to use "every full dose obtainable" to help speed up the nationwide immunization campaign.
Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.
States are starting to administer their first doses of Pfizer's newly FDA-authorized COVID-19 vaccine. It marks a new phase in the pandemic, but what's that mean for you?
As FDA emergency use authorization of Pfizer and Moderna vaccines nears, airlines, FedEx and UPS prepare to transport millions of vials of life saving shots.
The Food and Drug Administration's authorization of a COVID-19 vaccine could come in a day or two, a member of an FDA expert panel says. But he says it may be late 2021 before normalcy returns.
The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.
The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is designed for mild to moderate cases.